FASN inhibition as a potential treatment for endocrine-resistant breast cancer
Aleksandra Gruslova, Bryan McClellan, Henriette U. Balinda, Suryavathi Viswanadhapalli, Victoria Alers, Gangadhara R. Sareddy, Tim Huang, Michael Garcia, Linda A. deGraffenried, Ratna K. Vadlamudi, Andrew Brenner
Topics & Concepts
TamoxifenCancer researchBiologyFatty acid synthaseEndocrinologyInternal medicineBreast cancerEndoplasmic reticulumEndocrine systemCell growthCancerMedicineCell biologyHormoneLipid metabolismBiochemistryCancer, Lipids, and MetabolismPeroxisome Proliferator-Activated ReceptorsLipid metabolism and biosynthesis